Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited (KRSNAA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
krsnaadiagnostics.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 155 Cr | 158 Cr | 166 Cr | 170 Cr | 186 Cr | 175 Cr | 186 Cr | 193 Cr | 206 Cr | 181 Cr | 193 Cr | 236 Cr |
| Operating expenses (approx.) | 124 Cr | 121 Cr | 123 Cr | 128 Cr | 137 Cr | 129 Cr | 133 Cr | 142 Cr | 147 Cr | 135 Cr | 138 Cr | 178 Cr |
| EBITDA | 32 Cr | 37 Cr | 44 Cr | 43 Cr | 49 Cr | 45 Cr | 53 Cr | 51 Cr | 59 Cr | 46 Cr | 55 Cr | 58 Cr |
| OPM % | 20.4% | 23.6% | 26.3% | 25.1% | 26.5% | 25.8% | 28.5% | 26.6% | 28.7% | 25.6% | 28.5% | 24.6% |
| Other income | 4 Cr | 4 Cr | 4 Cr | 7 Cr | 5 Cr | 9 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 31 Cr | 7 Cr |
| Interest | 3 Cr | 4 Cr | 7 Cr | 5 Cr | 6 Cr | 6 Cr | 7 Cr | 6 Cr | 8 Cr | 8 Cr | 12 Cr | 15 Cr |
| Depreciation | 19 Cr | 21 Cr | 18 Cr | 21 Cr | 22 Cr | 23 Cr | 22 Cr | 22 Cr | 24 Cr | 23 Cr | 23 Cr | 28 Cr |
| Profit before tax | 13 Cr | 16 Cr | 23 Cr | 23 Cr | 25 Cr | 25 Cr | 29 Cr | 27 Cr | 32 Cr | 20 Cr | 52 Cr | 22 Cr |
| Tax % | 21.8% | 19.4% | 17.2% | 22.8% | 22.9% | 23.8% | 27.7% | 25.2% | 24.1% | 22.5% | 19.3% | 26.2% |
| Net profit | 10 Cr | 13 Cr | 19 Cr | 18 Cr | 20 Cr | 19 Cr | 21 Cr | 21 Cr | 24 Cr | 15 Cr | 42 Cr | 17 Cr |
| EPS (₹) | ₹3.35 | ₹4.09 | ₹5.80 | ₹5.55 | ₹6.07 | ₹6.01 | ₹6.40 | ₹6.35 | ₹7.38 | ₹4.72 | ₹12.86 | ₹5.10 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 455 Cr | 487 Cr | 620 Cr | 717 Cr | 773 Cr | Sign in for TTM |
| Operating expenses (approx.) | 324 Cr | 365 Cr | 475 Cr | 527 Cr | 561 Cr | Sign in for TTM |
| EBITDA | 131 Cr | 122 Cr | 144 Cr | 190 Cr | 212 Cr | Sign in for TTM |
| OPM % | 28.9% | 25.1% | 23.3% | 26.5% | 27.4% | Sign in for TTM |
| Other income | 15 Cr | 19 Cr | 17 Cr | 26 Cr | 43 Cr | Sign in for TTM |
| Interest | 18 Cr | 8 Cr | 16 Cr | 25 Cr | 34 Cr | Sign in for TTM |
| Depreciation | 41 Cr | 54 Cr | 75 Cr | 88 Cr | 90 Cr | Sign in for TTM |
| Profit before tax | 87 Cr | 80 Cr | 70 Cr | 103 Cr | 130 Cr | Sign in for TTM |
| Tax % | 20.9% | 22.6% | 18.8% | 24.4% | 22.2% | Sign in for TTM |
| Net profit | 68 Cr | 62 Cr | 57 Cr | 78 Cr | 101 Cr | Sign in for TTM |
| EPS (₹) | ₹22.89 | ₹19.78 | ₹17.90 | ₹24.04 | ₹31.30 | Sign in for TTM |
| Dividend payout % | 0.0% | 12.6% | 15.2% | 10.4% | 8.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 16 Cr | 16 Cr | 16 Cr | 16 Cr | 16 Cr |
| Reserves | 669 Cr | 723 Cr | 794 Cr | 867 Cr | 964 Cr |
| Borrowings | 41 Cr | 32 Cr | 160 Cr | 204 Cr | 534 Cr |
| Other liabilities | 151 Cr | 139 Cr | 202 Cr | 195 Cr | 309 Cr |
| Total liabilities | 876 Cr | 910 Cr | 1,172 Cr | 1,282 Cr | 1,824 Cr |
| Fixed assets (net) | 383 Cr | 468 Cr | 645 Cr | 667 Cr | 652 Cr |
| CWIP | 28 Cr | 25 Cr | 10 Cr | 3 Cr | 208 Cr |
| Investments | 0.29 Cr | 0.29 Cr | 0.29 Cr | 32 Cr | 57 Cr |
| Inventories | 9 Cr | 25 Cr | 36 Cr | 29 Cr | 27 Cr |
| Trade receivables | 58 Cr | 73 Cr | 176 Cr | 278 Cr | 296 Cr |
| Cash & bank | 88 Cr | 23 Cr | 2 Cr | 4 Cr | 30 Cr |
| Other assets | 309 Cr | 295 Cr | 303 Cr | 269 Cr | 554 Cr |
| Total assets | 876 Cr | 910 Cr | 1,172 Cr | 1,282 Cr | 1,824 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 128 Cr | 76 Cr | 24 Cr | 87 Cr | 143 Cr |
| Cash from investing | -241 Cr | -109 Cr | -129 Cr | -100 Cr | -396 Cr |
| Cash from financing | 176 Cr | -33 Cr | 84 Cr | 14 Cr | 279 Cr |
| Net cash flow | 64 Cr | -66 Cr | -20 Cr | 1 Cr | 26 Cr |
| Free cash flow (OCF − Capex) | -4 Cr | -65 Cr | -170 Cr | -39 Cr | -76 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 15.3% | 11.4% | 8.9% | 11.7% | 10.9% |
| ROE % | 10.0% | 8.4% | 7.0% | 8.8% | 10.3% |
| Debtor days | 46 | 55 | 104 | 141 | 139 |
| Inventory days | 55 | 123 | 93 | 63 | 54 |
| Days payable | 467 | 305 | 213 | 209 | 128 |
| Cash conversion cycle | -365 | -127 | -17 | -5 | 65 |
| Debt / equity | 0.06 | 0.04 | 0.20 | 0.23 | 0.55 |
| Current ratio | 2.25 | 2.28 | 1.50 | 1.36 | 2.68 |
| Net debt / EBITDA | 0.00 | 0.08 | 1.09 | 1.05 | 2.38 |
Compare with peers
Loading peers…